V1591: Robotic Microsurgical Vasectomy Reversal: Initial Experience and Surgical Outcomes from a Single Academic Center.
VideoIntroduction and Objectives
The Robotic platform has emerged as a feasible alternative to the traditional microsurgical vasectomy reversal (MSVR) with the operating microscope. Potential advantages of the robotic platform are stereotactic vision, increased surgeon autonomy (assisting with the 4th arm), lack of tremor, and improved ergonomics. We report our initial experience and outcomes for robotic microsurgical vasectomy reversal (RMVR) at a large academic center.
We retrospectively reviewed surgical outcomes for a single surgeon at an academic center from 2011 to 2012. All patients that underwent surgery were included in the study. Residents and fellows were involved in all procedures. All patients underwent vasectomy reversal with the DaVinci robotic platform with the dual console. Demographic information, operative times, and outcomes were recorded. Statistical analysis was performed with a one-way ANOVA test.
Results are shown in Table 1. 6 out of 11 patients had their follow up sperm check and all had motile sperm at an average of 7 weeks. Figure 1 shows the breakdown of procedures performed. Figure 2 shows the number of years from vasectomy for all subjects.
RMSVR is safe and effective with good initial success rates at short term follow up. In addition it provided stereotactic vision, improved ergonomics, and a unique more controlled microsurgical training environment for residents and fellows.